Pertussis Across the Globe: Recent Epidemiologic Trends From 2000 to 2013

No abstract is available for this paper.

• Publication year

  2015

• Venue

  The Pediatric Infectious Disease Journal

• Publication date

  2015-06-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/INF.0000000000000795PMID 26376316
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage.

  2015cited by this paper
• Genomic analysis of isolates from the United Kingdom 2012 pertussis outbreak reveals that vaccine antigen genes are unusually fast evolving.

  2015cited by this paper
• Noninfluenza Vaccination Coverage Among Adults — United States, 2012

  2014cited by this paper
• Receipt of pertussis vaccine during pregnancy across 7 Vaccine Safety Datalink sites.

  2014cited by this paper
• Pertussis: A Global Perspective.

  2014cited by this paper
• Rapid Increase in Pertactin-deficient Bordetella pertussis Isolates, Australia

  2014cited by this paper
• The Danish Microbiology Database (MiBa) 2010 to 2013.

  2014cited by this paper
• Prevalence of asymptomatic Bordetella pertussis and Bordetella parapertussis infections among school children in China as determined by pooled real-time PCR: A cross-sectional study

  2014cited by this paper
• European Centre for Disease Prevention and Control.

  2014cited by this paper
• Pertussis in Latin America: epidemiology and control strategies

  2014cited by this paper
• Epidemiology of pertussis in an urban region of Poland: time for a booster for adolescents and adults.

  2013cited by this paper
• The UK pertussis epidemic: implications for immunisation.

  2013cited by this paper
• National and State Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2012

  2013cited by this paper
• [Pertussis vaccination coverage among adults in Germany].

  2013cited by this paper
• Can vaccine legacy explain the British pertussis resurgence?

  2013cited by this paper
• Pertussis resurgence: waning immunity and pathogen adaptation – two sides of the same coin

  2013cited by this paper
• Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience.

  2013cited by this paper
• Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model

  2013cited by this paper
• Pertussis-Impfquoten bei Erwachsenen in Deutschland

  2013cited by this paper
• The seroprevalence of Bordetella pertussis antibodies in adolescents in the Western Cape

  2013cited by this paper
• Prospective Nationwide Surveillance of Hospitalizations Due to Pertussis in Children, 2006–2010

  2013cited by this paper
• Pertussis vaccines: Position paper of Indian Academy of Pediatrics (IAP)

  2013cited by this paper
• Prevalence and Molecular Characterization of Pertactin-Deficient Bordetella pertussis in the United States

  2013cited by this paper
• Deciphering the impacts of vaccination and immunity on pertussis epidemiology in Thailand

  2013cited by this paper
• Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort.

  2013cited by this paper
• Comparative Effectiveness of Acellular Versus Whole-Cell Pertussis Vaccines in Teenagers

  2013cited by this paper
• Genetic Analysis of Bordetella pertussis Isolates from the 2008–2010 Pertussis Epidemic in Japan

  2013cited by this paper
• The implementation of Integrated Disease Surveillance and Response in Uganda: a review of progress and challenges between 2001 and 2007

  2012cited by this paper
• Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010.

  2012cited by this paper
• Clinical Definitions of Pertussis: Summary of a Global Pertussis Initiative Roundtable Meeting, February 2011

  2012cited by this paper
• Re-emergence of diphtheria and pertussis: implications for Nigeria.

  2012cited by this paper
• Pertussis Epidemiology in Greece and Emerging Risk Groups during the Vaccination Era (1980–2008)

  2012cited by this paper
• Waning protection after fifth dose of acellular pertussis vaccine in children.

  2012cited by this paper
• Selection and emergence of pertussis toxin promoter ptxP3 allele in the evolution of Bordetella pertussis.

  2012cited by this paper
• National pertussis surveillance in South Korea 1955-2011: epidemiological and clinical trends.

  2012cited by this paper
• Pertussis resurgence among vaccinated children in Khairpur, Sindh, Pakistan.

  2012cited by this paper
• Population Diversity among Bordetella pertussis Isolates, United States, 1935–2009

  2012cited by this paper
• Early Impact of the US Tdap vaccination program on pertussis trends.

  2012cited by this paper
• High heterogeneity in methods used for the laboratory confirmation of pertussis diagnosis among European countries, 2010: integration of epidemiological and laboratory surveillance must include standardisation of methodologies and quality assurance.

  2012cited by this paper
• Pertussis: A Review of Disease Epidemiology Worldwide and in Italy

  2012cited by this paper
• Prevalence of Bordetella pertussis and Bordetella parapertussis infections in Tunisian hospitalized infants: results of a 4-year prospective study.

  2012cited by this paper
• Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000.

  2012cited by this paper
• Pertussis (whooping cough) epidemiology in Waikato, New Zealand: 2000-2009.

  2011cited by this paper
• Pertussis incidence among adolescents and adults surveyed in general practices in the Paris area, France, May 2008 to March 2009.

  2011cited by this paper
• Prospective pertussis surveillance in Switzerland, 1991-2006.

  2011cited by this paper
• Recommendation for the use of newly introduced Tdap vaccine in Korea

  2011cited by this paper
• Vaccination coverage and timeliness in three South African areas: a prospective study

  2011cited by this paper
• The incidence of pertussis hospitalizations among Japanese infants: excess hospitalizations and complications?

  2011cited by this paper
• Pertussis resurgence in Toronto, Canada: a population-based study including test-incidence feedback modeling

  2011cited by this paper
• Epidemiology of pertussis in a country with high vaccination coverage.

  2011cited by this paper
• The impact of adolescent pertussis immunization, 2004-2009: lessons from Australia.

  2011cited by this paper
• The Global Pertussis Initiative: report from a round table meeting to discuss the epidemiology and detection of pertussis, Paris, France, 11-12 January 2010.

  2011cited by this paper
• Infant pertussis epidemiology and implications for tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccination: King County, Washington, 2002 through 2007.

  2011cited by this paper
• The Global Pertussis Initiative: Meeting report from the fourth regional roundtable meeting, France, April 14-15, 2010

  2011cited by this paper
• Review of the 2008-2009 pertussis epidemic in NSW: notifications and hospitalisations.

  2010cited by this paper
• Pediatric disease burden and vaccination recommendations: understanding local differences.

  2010cited by this paper
• A steady rise in incidence of pertussis since nineties in the Czech Republic.

  2010cited by this paper
• Pertussis in Florida, 2000–2006: Trends in a Historically Low-Incidence State

  2010cited by this paper
• The impact of additional pertussis vaccine doses on disease incidence in children and infants.

  2010cited by this paper
• Global, regional, and national causes of child mortality in 2008: a systematic analysis.

  2010cited by this paper
• Determinants of third dose of diphtheria–tetanus–pertussis (DTP) completion among children who received DTP1 at rural immunization centres in Pakistan: a cohort study

  2010cited by this paper
• Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen.

  2010cited by this paper
• The seroepidemiology of Bordetella pertussis in Israel--Estimate of incidence of infection.

  2010cited by this paper
• Outbreak of Bordetella pertussis among oncology nurse specialists.

  2010cited by this paper
• Strengthening public health surveillance and response using the health systems strengthening agenda in developing countries

  2010cited by this paper
• Epidemiological characteristics of pertussis in Estonia, Lithuania, Romania, the Czech Republic, Poland and Turkey—1945 to 2005

  2009cited by this paper
• Pertussis in Afghanistan, 2007–2008

  2009cited by this paper
• An outbreak of pertussis in Sarli Circle of Kurung-kumey district, Arunachal Pradesh, India.

  2009cited by this paper
• Pertussis before and after the introduction of acellular pertussis vaccines in Finland.

  2009cited by this paper
• Epidemiology of Pertussis and Haemophilus influenzae type b Disease in Canada With Exclusive Use of a Diphtheria-Tetanus-Acellular Pertussis-Inactivated Poliovirus-Haemophilus influenzae type b Pediatric Combination Vaccine and an Adolescent-Adult Tetanus-Diphtheria-Acellular Pertussis Vaccine: Impl

  2009cited by this paper
• Pertussis epidemiology in Argentina: trends over 2004-2007.

  2009cited by this paper
• Recent findings on pertussis epidemiology in Turkey

  2008cited by this paper
• [Epidemiological profile of pertussis in Rio Grande do Sul State, Brazil: a study of the correlation between incidence and vaccine coverage].

  2008cited by this paper
• High prevalence of antibody titers against Bordetella pertussis in an adult population with prolonged cough.

  2008cited by this paper
• The Effect of Changing From Whole-Cell to Acellular Pertussis Vaccine on the Epidemiology of Hospitalized Children With Pertussis in Canada

  2007cited by this paper
• Incidence trends in pertussis in the Autonomous Region of Madrid, Spain: 1982-2005.

  2007cited by this paper
• Epidemiological shift in the prevalence of pertussis in Taiwan: implications for pertussis vaccination.

  2007cited by this paper
• EPIREVIEW. Pertussis in New South Wales, 1993-2005: the impact of vaccination policy on pertussis epidemiology.

  2007cited by this paper
• High incidence of Pertussis among schoolchildren with prolonged cough in Turkey.

  2007cited by this paper
• The epidemiology of pertussis in the Australian Capital Territory, 1999 to 2005--epidemics of testing, disease or false positives?

  2007cited by this paper
• Pertussis epidemiology in Australia over the decade 1995-2005--trends by region and age group.

  2007cited by this paper
• Cost effectiveness of pertussis vaccination in adults.

  2007cited by this paper
• Impact of a Pertussis Booster Vaccination Program in Adolescents and Adults on the Epidemiology of Pertussis in Austria

  2007cited by this paper
• Immunization rates and timely administration in pre-school and school-aged children

  2006cited by this paper
• Significant Gene Order and Expression Differences in Bordetella pertussis Despite Limited Gene Content Variation

  2006cited by this paper
• [Pertussis: incidence, symptoms and costs].

  2006cited by this paper
• Pertussis in rural populations of Saskatchewan (1995 to 2003): incidence, seasonality, and differences among cases.

  2006cited by this paper
• Public Health Surveillance: A Tool for Targeting and Monitoring Interventions

  2006cited by this paper
• Pertussis bei Erwachsenen: Häufigkeit, Symptome und Kosten

  2006cited by this paper
• Epidemiology of pertussis.

  2005cited by this paper
• Pertussis Sources of Infection and Routes of Transmission in the Vaccination Era

  2005cited by this paper
• Resurgence of Pertussis in Europe

  2005cited by this paper
• [Effect of vaccination against pertussis on the incidence of pertussis in The Netherlands, 1996-2003].

  2005cited by this paper
• The Epidemiology of Pertussis: A Comparison of the Epidemiology of the Disease Pertussis With the Epidemiology of Bordetella pertussis Infection

  2005cited by this paper
• Analysis of Bordetella pertussis Populations in European Countries with Different Vaccination Policies

  2005cited by this paper
• Sero-epidemiology of Bordetella pertussis in England and Wales.

  2004cited by this paper
• Infant Pertussis: Who Was the Source?

  2004cited by this paper
• Sero epidemiology of Bordetella pertussis immune responses in a healthy population in northern Greece

  2004cited by this paper
• Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine.

  2003cited by this paper
• Infantile Pertussis Rediscovered in China

  2002cited by this paper

• Pertussis Outbreak Investigation in a Korean Middle School: Insights on Tdap and Td Vaccination

  2026cites this paper
• Global variations in immunisation strategies against pertussis in infancy

  2025cites this paper
• Understanding the Epidemiology and Contributing Factors of Post-COVID-19 Pertussis Outbreaks: A Narrative Review

  2025cites this paper
• Epidemiological investigation of a pertussis outbreak among schoolchildren in Burkina Faso, 2019

  2025cites this paper
• Acute Interstitial Nephritis Associated to Pertussis Infection: A Case Report and Review of the Literature

  2025cites this paper
• Pertussis hospitalizations in France (2008-2020): A real-world retrospective analysis of incidence and costs based on the French National Health Data System.

  2025cites this paper
• Global, regional and national trends in incidence and mortality of pertussis from 1990 to 2021 and the comparison before and during COVID-19: A modelling analysis.

  2025cites this paper
• Trends and Characteristics of Pertussis Epidemic in Pediatric Patients During and After the COVID-19 Pandemic in East China

  2025cites this paper
• Closing the pertussis immunity gap: vaccine equity saves infant lives.

  2025cites this paper
• Co-administration of vaccines in pregnancy: unique challenges and knowledge gaps.

  2025cites this paper
• Maternal Vaccination as an Integral Part of Life-Course Immunization: A Scoping Review of Uptake, Barriers, Facilitators, and Vaccine Hesitancy for Antenatal Vaccination in Ireland

  2025cites this paper
• Resurgence of pertussis: Epidemiological trends, contributing factors, challenges, and recommendations for vaccination and surveillance

  2025cites this paper
• Structural and functional specialization of Bordetella pertussis DsbA for pertussis toxin folding

  2025cites this paper
• Pertussis resurgence: epidemiological trends, pathogenic mechanisms, and preventive strategies

  2025cites this paper
• A highly conserved sRNA downregulates multiple genes, including a σ54 transcriptional activator, in the virulence mode of Bordetella pertussis

  2025cites this paper
• Bordetella pertussis exhibits genomic diversity within patients and laboratory culture

  2025cites this paper
• Case Report: Co-infection of tuberculosis and pertussis in a 47-day-old infant and therapeutic strategies

  2025cites this paper
• Emergence of Bordetella holmesii–Associated Pertussis-Like Illness, Northern India, 2019–2023

  2025cites this paper
• Comparing Respiratory Illness Surveillance Case Definitions to Detect Bordetella pertussis in Children Aged <5 Years With Respiratory Illness in South Africa, 2017–2023

  2025cites this paper
• Combined short-term exposure to meteorological, pollution factors and pertussis in different groups from Jining, China

  2024cites this paper
• A highly conserved sRNA downregulates multiple genes, including a σ54 transcriptional activator, in the virulence mode of Bordetella pertussis

  2024cites this paper
• Safety, Efficacy, and Effectiveness of Maternal Vaccination against Respiratory Infections in Young Infants

  2024cites this paper
• Mechanisms and Implications of IgG4 Responses to SARS-CoV-2 and Other Repeatedly Administered Vaccines.

  2024cites this paper
• Effect of HIV and Malaria in Pregnancy on Pertussis-specific Antibodies and Transplacental Antibody Transfer: A Secondary Analysis of a Prospective Cohort Study in Mozambican Pregnant Women and Their Infants

  2024cites this paper
• Epidemiological characteristics and survival analysis of pertussis in Quzhou

  2024cites this paper
• Acceptance and uptake of vaccines against tetanus, influenza, pertussis, and COVID-19 among pregnant and postpartum women in low- and middle-income countries: a systematic review and meta-analysis protocol

  2024cites this paper
• A multi-omics systems vaccinology resource to develop and test computational models of immunity

  2024cites this paper
• A whole-cell pertussis vaccine engineered to elicit reduced reactogenicity protects baboons against pertussis challenge

  2024cites this paper
• The current state of pertussis vaccination in pregnancy around the world, with recommendations for improved care: Consensus statements from the Global Pertussis Initiative

  2024cites this paper
• Pertussis Notification Rate and Tdpa Vaccine/Booster Coverage in Adults: An Opportunity for an Epidemiological Observatory in Primary Care

  2024cites this paper
• Mucosal vaccination with outer membrane vesicles derived from Bordetella pertussis reduces nasal bacterial colonization after experimental infection

  2024cites this paper
• Predictors of maternal pertussis vaccination acceptance among pregnant women in Norway

  2024cites this paper
• US Infant Pertussis Incidence Trends Before and After Implementation of the Maternal Tetanus, Diphtheria, and Pertussis Vaccine.

  2023cites this paper
• Distinct early cellular kinetics in participants protected against colonization upon Bordetella pertussis challenge

  2023cites this paper
• Pertussis epidemiology in Canada, 2005–2019

  2023cites this paper
• Immunization with autotransporter Vag8 prevents coughing induced by Bordetella pertussis infection in mice

  2023cites this paper
• Assessment of Pertussis Underreporting in Italy

  2023cites this paper
• Vaccination against pertussis in Latin American preterm and low-birth weight infants: experts opinion position for a neglected childhood age group

  2023cites this paper
• Comparison of Immunogenicity and Safety of Diphtheria–Tetanus–Pertussis–Hepatitis B–Haemophilus influenza B (Bio Farma) with Pentabio® Vaccine Primed with Recombinant Hepatitis B at Birth (Using Different Source of Hepatitis B) in Indonesian Infants

  2023cites this paper
• Combined regulation of pro-inflammatory cytokines production by STAT3 and STAT5 in a model of B. pertussis infection of alveolar macrophages

  2023cites this paper
• Impact of maternal whole-cell or acellular pertussis primary immunization on neonatal immune response

  2023cites this paper
• Development of an algorithm for finding pertussis episodes in a population-based electronic health record database

  2023cites this paper
• Evaluation of serum anti-pertussis toxin IgA antibodies for the diagnosis of Bordetella pertussis infection in young children.

  2023cites this paper
• Domination of an emerging erythromycin-resistant ptxP3 Bordetella pertussis clone in Shanghai, China.

  2023cites this paper
• Impact of pregnancy on polyfunctional IgG and memory B cell responses to Tdap immunization.

  2023cites this paper
• Vaccination in Pregnancy against Pertussis: A Consensus Statement on Behalf of the Global Pertussis Initiative

  2022cites this paper
• Sero-Epidemiological Study of Bordetella pertussis Infection in the Italian General Population

  2022cites this paper
• Evaluation of Whole-Cell and Acellular Pertussis Vaccines in the Context of Long-Term Herd Immunity

  2022cites this paper
• Experts’ Opinion for Improving Pertussis Vaccination Rates in Adolescents and Adults: A Call to Action

  2022cites this paper
• Pertussis surveillance results from a French general practitioner network, France, 2017 to 2020

  2022cites this paper
• The whole-cell pertussis vaccine imposes a broad effector B cell response in mouse heterologous prime-boost settings

  2022cites this paper
• Effects and interaction of air pollution and meteorological factors on pertussis incidence in P.R.China

  2022cites this paper
• Reduced Bordetella pertussis-specific CD4+ T-Cell Responses at Older Age

  2022cites this paper
• BCG-induced trained immunity enhances acellular pertussis vaccination responses in an explorative randomized clinical trial

  2022cites this paper
• Age and Primary Vaccination Background Influence the Plasma Cell Response to Pertussis Booster Vaccination

  2022cites this paper
• Risk factors and prediction model of severe pertussis in infants < 12 months of age in Tianjin, China

  2022cites this paper
• Genome Characteristic of Bordetella parapertussis Isolated from Iran

  2022cites this paper
• Association Between Real-time Polymerase Chain Reaction Cycle Threshold Value and Clinical Severity in Neonates and Infants Infected With Bordetella pertussis

  2022cites this paper
• RETRACTED: The Mechanism of Pertussis Cough Revealed by the Mouse-Coughing Model

  2022cites this paper
• A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of childbearing age

  2021cites this paper
• Evaluation of B-Cell Kinetics After Acellular Pertussis Vaccination in Four Cohorts of Different Age and Priming Background

  2021cites this paper
• Real-life requests for Bordetella polymerase chain reaction testing in children presenting to hospital.

  2021cites this paper
• The impact of pertussis in infants: insights from a hospital-based enhanced surveillance system, Lazio region, Italy, 2016 to 2019

  2021cites this paper
• Evaluation of Outer Membrane Vesicles Obtained from Predominant Local Isolate of Bordetella pertussis as a Vaccine Candidate

  2021cites this paper
• Whether Urbanization Has Intensified the Spread of Infectious Diseases—Renewed Question by the COVID-19 Pandemic

  2021cites this paper
• Modification of innate immune responses to Bordetella pertussis in babies from pertussis vaccinated pregnancies

  2021cites this paper
• Identification of BvgA-Dependent and BvgA-Independent Small RNAs (sRNAs) in Bordetella pertussis Using the Prokaryotic sRNA Prediction Toolkit ANNOgesic

  2021cites this paper
• Pertussis Vaccine Candidate Based on Outer Membrane Vesicles Derived From Biofilm Culture

  2021cites this paper
• Highly Sensitive Flow Cytometry Allows Monitoring of Changes in Circulating Immune Cells in Blood After Tdap Booster Vaccination

  2021cites this paper
• EPIDEMIOLOGICAL ANALIYSIS OF PERTUSSIS MORBIDITY IN UKRAINE.

  2021cites this paper
• Expression of Bordetella pertussis Antigens Fused to Different Vectors and Their Effectiveness as Vaccines

  2021cites this paper
• Emerging macrolide resistance in Bordetella pertussis in mainland China: Findings and warning from the global pertussis initiative

  2021cites this paper
• Lessons from a mature acellular pertussis vaccination program and strategies to overcome suboptimal vaccine effectiveness

  2021cites this paper
• Differences between influenza and pertussis vaccination uptake in pregnancy: a multi-center survey study in Italy.

  2021cites this paper
• Is there a potential for novel, nasal pertussis vaccines?

  2021cites this paper
• Epidemiology of pertussis in Costa Rica and the impact of vaccination: A 58-year experience (1961-2018).

  2021cites this paper
• Obstetric and perinatal health outcomes after pertussis vaccination during pregnancy in Ontario, Canada: a retrospective cohort study

  2021cites this paper
• Incidence and severity of pertussis hospitalisations in infants aged less than 1 year in 37 hospitals of six EU/EEA countries, results of PERTINENT sentinel pilot surveillance system, December 2015 to December 2018

  2021cites this paper
• Impact of Tdap vaccine during pregnancy on the incidence of pertussis in children under one year in Brazil - A time series analysis.

  2021cites this paper
• Epidemiology of pertussis in individuals of all ages hospitalised with respiratory illness in South Africa, January 2013 - December 2018.

  2021cites this paper
• Effect of a postpartum prescription for pertussis vaccine: a before-and-after study.

  2021cites this paper
• Pertussis vaccines and the role of Bordetella pertussis lipooligosaccharide in the immune response to pertussis infection and vaccination

  2021cites this paper
• Risk factors for Bordetella pertussis disease in hospitalized children

  2020cites this paper
• Effect of Macrolides and β-lactams on Clearance of Bordetella pertussis in the Nasopharynx in Children With Whooping Cough.

  2020cites this paper
• Azithromycin to Prevent Pertussis in Household Contacts, Catalonia and Navarre, Spain, 2012–2013

  2020cites this paper
• Incidence and mortality of pertussis disease in infants <12 months of age following introduction of pertussis maternal universal mass vaccination in Bogotá, Colombia.

  2020cites this paper
• Canonical and Non-canonical Inflammasome Activation by Outer Membrane Vesicles Derived From Bordetella pertussis

  2020cites this paper
• The burden of laboratory-confirmed pertussis in low- and middle-income countries since the inception of the Expanded Programme on Immunisation (EPI) in 1974: a systematic review and meta-analysis

  2020cites this paper
• A systematic review of the burden of pertussis disease in infants and the effectiveness of maternal immunization against pertussis

  2020cites this paper
• Innate Lymphoid Cells: Important Regulators of Host–Bacteria Interaction for Border Defense

  2020cites this paper
• Re-emergence of an Old Threat: Is it Time to Revise Our National Immunization Schedule?

  2020cites this paper
• Pertussis

  2020cites this paper
• A system-view of B. pertussis booster vaccine responses in adults primed with whole-cell vs. acellular vaccine in infancy

  2020cites this paper
• Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study.

  2020cites this paper
• Assessment of IgA anti-PT and IgG anti-ACT reflex testing to improve Bordetella pertussis serodiagnosis in recently vaccinated subjects.

  2020cites this paper
• Pertussis in early life: underdiagnosed, severe, and risky disease. A seven-year experience in a pediatric tertiary-care hospital

  2020cites this paper
• Use of a Neonatal-Mouse Model to Characterize Vaccines and Strategies for Overcoming the High Susceptibility and Severity of Pertussis in Early Life

  2020cites this paper
• Pertussis in high-risk groups: an overview of the past quarter-century

  2020cites this paper
• A data driven clinical algorithm for differential diagnosis of pertussis and other respiratory infections in infants

  2020cites this paper
• Comparative genomics of whole-cell pertussis vaccine strains from India

  2020cites this paper